Dark

IART
Integra LifeSciences Holdings
stock NASDAQ

At Close

Jul 3, 2025 12:59:56 PM EDT

13.48USD-0.333%(-0.04)759,134

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 3, 2025 8:02:30 AM EDT

13.53USD+0.074%(+0.01)108

After-hours

Jul 2, 2025 4:09:30 PM EDT

13.46USD-0.370%(-0.05)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 18, 2022

09:52AM EST Price Over Earnings Overview: Integra Lifesciences Benzinga

09:28AM EST B of A Securities Maintains Underperform on Integra Lifesciences, Raises Price Target to $65 Benzinga

Jan 12, 2022

05:58AM EST A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Consumer Price Index Benzinga

05:57AM EST Integra LifeSciences Reports Interim Q4 Sales Marginally Ahead Of Expectations Benzinga

Jan 11, 2022

04:31PM EST Integra LifeSciences Says Planning $125M Buyback As Part Of Previous Approval For Up To $225M Repurchase Authorization Benzinga

04:31PM EST Integra LifeSciences Sees Q4 Sales $404M-$406M vs $403.9M Estimate; FY21 Sales $1.541B-$1.543B vs $1.54B Est. Benzinga

04:30PM EST Integra LifeSciences Reports Preliminary Fourth Quarter and GlobeNewswire Inc

Dec 21, 2021

04:37PM EST BD Announces Board of Directors for embecta, the Planned Spinoff of its PR Newswire

Dec 17, 2021

10:18AM EST Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021 Benzinga

05:07AM EST JP Morgan Upgrades Integra Lifesciences to Neutral, Announces $75 Price Target Benzinga

Nov 3, 2021

09:21AM EDT Credit Suisse Maintains Outperform on Integra Lifesciences, Raises Price Target to $87 Benzinga

Nov 2, 2021

10:54AM EDT The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US Benzinga

10:47AM EDT Integra Lifesciences Sees Q4 EPS $0.82-$0.86 Vs. $0.81 Est. Sales $403M Vs. $409.65M Est.; Raises FY21 EPS Guidance From $2.98-$3.05 To $3.16-$3.20 Vs. $3.02 Est. Benzinga

10:45AM EDT Integra Lifesciences Q3 EPS $0.86 Beats $0.72 Estimate, Sales $386.86M Beat $384.58M Estimate Benzinga

10:41AM EDT Earnings Scheduled For November 2, 2021 Benzinga

07:03AM EDT Integra LifeSciences Holdings Corporation (IART) on Tuesday reported higher earnings in the third quarter driven by strength across most of its product portfolio. The company also raised its full-year adjusted earnings outlook, better than analysts' view. RTTNews

06:07AM EDT Integra Lifesciences Q3 GAAP EPS $0.51; Adj EPS $0.86 RTTNews

06:00AM EDT Integra LifeSciences Reports Third Quarter 2021 Financial Results GlobeNewswire Inc

Oct 31, 2021

02:24PM EDT The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline Benzinga

Oct 28, 2021

08:39AM EDT Integra LifeSciences Appoints Jan De Witte As President And Chief Executive Officer Benzinga

08:30AM EDT Integra LifeSciences Announces Jan De Witte as President and Chief GlobeNewswire Inc

Oct 6, 2021

04:01PM EDT Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2021 financial results on Tuesday, November 2, 2021, prior to the market open. In conjunction with the earnings release, Integras management team will host a conference call at 8:30 a.m. ET. GlobeNewswire Inc

Sep 15, 2021

10:05AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2021 Benzinga

07:35AM EDT BTIG Downgrades Integra Lifesciences to Neutral Benzinga

Sep 2, 2021

04:01PM EDT Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in the following investor conferences: GlobeNewswire Inc

Jul 28, 2021

02:29PM EDT Integra's Update On FY21 Acell Revenues To Weigh On Stock, Piper Sandler Says Benzinga

09:16AM EDT While reporting financial results for the second quarter on Wednesday, medical technology company Integra LifeSciences Holdings Corp. (IART) raised its adjusted earnings and revenue guidance for the full-year 2021, based on better than expected second quarter financial performance. The company also issued outlook for the third quarter. RTTNews

08:43AM EDT Integra Lifesciences Q2 GAAP EPS $0.41; Adj EPS $0.79 RTTNews

07:33AM EDT The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal Benzinga

07:14AM EDT Recap: Integra Lifesciences Q2 Earnings Benzinga

06:20AM EDT Integra LifeSciences Raises FY21 EPS Guidance From $2.86-$2.93 To $2.98-$3.05 Vs. $2.92 Est., Raises FY21 Sales Guidance From $1.525B-$1.535B To $1.54B-$1.55B Vs. $1.53B Est. Benzinga

06:18AM EDT Integra Lifesciences Q2 EPS $0.79 Beats $0.66 Estimate, Sales $389.99M Beat $376.01M Estimate Benzinga

06:00AM EDT Integra LifeSciences Reports Second Quarter 2021 Financial Results GlobeNewswire Inc

04:27AM EDT Earnings Scheduled For July 28, 2021 Benzinga

Jul 25, 2021

10:05AM EDT The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More Benzinga

Jul 20, 2021

08:20AM EDT The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street Benzinga

Jul 19, 2021

04:32PM EDT Integra Lifesciences Reports Clinical Outcomes Of PriMatrix Dermal Repair Scaffold For Mgmt. Of Diabetic Foot Ulcers: With 100+ Patients Per Treatment Group, Showed 'in most cases, one application of PriMatrix plus standard of care (SOC) healed 60% of DFU Benzinga

04:30PM EDT Integra LifeSciences Announces Positive Clinical Outcomes for GlobeNewswire Inc

Jul 14, 2021

04:33PM EDT Integra LifeSciences Receives Innovative Technology Contract From Vizient For SurgiMend Collagen Matrix For Soft Tissue Reconstruction Benzinga

04:32PM EDT Integra LifeSciences Receives Innovative Technology Contract from GlobeNewswire Inc

Jun 24, 2021

08:42AM EDT Integra LifeSciences Reports CEO Peter Arduini To Step Down; Board Has Initiated Formal Search For New Pres, CEO Benzinga

08:30AM EDT Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that Peter Arduini will step down as Chief Executive Officer at the end of 2021 to accept the role of President and Chief Executive Officer of GE Healthcare. GlobeNewswire Inc

May 20, 2021

06:00AM EDT Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will host an Investor Day meeting from 8:30 a.m. to approximately 12:30 p.m. ET, today May 20, 2021. GlobeNewswire Inc

May 7, 2021

08:30AM EDT Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will host an Investor Day meeting from 8:30 a.m. to approximately 12:30 p.m., U.S. eastern time on May 20, 2021. GlobeNewswire Inc

Apr 29, 2021

08:15AM EDT The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx Benzinga

Apr 28, 2021

12:00PM EDT Integra Lifesciences shares were trading higher after the company reported better-than-expected Q1 EPS and sales results. Benzinga

07:26AM EDT The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping Benzinga

07:11AM EDT Integra Lifesciences: Q1 Earnings Insights Benzinga

06:20AM EDT Integra Lifesciences Q1 EPS $0.69 Beats $0.57 Estimate, Sales $360.07M Beat $349.81M Estimate Benzinga

06:20AM EDT Integra LifeSciences Holdings Corp. (IART) reported first quarter adjusted earnings per share of $0.69, compared to $0.48, prior year. On average, 13 analysts polled by Thomson Reuters expected the company to report profit per share of $0.57, for the quarter. Analysts' estimates typically exclude special items. RTTNews

06:06AM EDT Integra LifeSciences Q1 GAAP EPS $0.53 Vs $0.11 Last Year RTTNews

06:00AM EDT Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March31, 2021. GlobeNewswire Inc

04:15AM EDT Earnings Scheduled For April 28, 2021 Benzinga

Apr 27, 2021

07:41AM EDT The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout Benzinga

Apr 24, 2021

09:24AM EDT The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx Benzinga

Apr 23, 2021

07:28AM EDT The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs Benzinga

Apr 22, 2021

08:09AM EDT The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs Benzinga

Apr 21, 2021

07:31AM EDT The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue Benzinga

Apr 19, 2021

04:56PM EDT Integra Issues Statement On FDA Communication On Differences In Complication Rates Between ADM Products RTTNews

04:15PM EDT Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company and manufacturer of SurgiMend Collagen Matrix, today issued the following statement regarding the U.S. FDA safety communication on the differences in complication rates between acellular dermal matrix (ADM) products used in implant-based breast reconstruction. GlobeNewswire Inc

Apr 8, 2021

04:00PM EDT Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2021 financial results on Wednesday, April 28, 2021 prior to market open. In conjunction with the earnings release, Integras management team will host a conference call at 8:30 a.m. ET. GlobeNewswire Inc

Apr 1, 2021

04:15PM EDT Integra LifeSciences Holdings Corporation(Nasdaq:IART), a leading global medical technology company, today announced the appointment of Shaundra Clay to its board of directors, effective today. GlobeNewswire Inc

Feb 19, 2021

09:07AM EST Credit Suisse Maintains Outperform on Integra Lifesciences, Raises Price Target to $79 Benzinga

08:00AM EST Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in the following investor conferences: GlobeNewswire Inc

Feb 18, 2021

08:14AM EST The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout Benzinga

07:47AM EST Recap: Integra Lifesciences Q4 Earnings Benzinga

07:40AM EST Integra Lifesciences' Q4 Earnings Come In Above Expectations, Issues Soft Q1 Guidance Benzinga

06:30AM EST While reporting financial results for the fourth quarter on Thursday, medical technology company Integra LifeSciences Holdings Corp. (IART) initiated adjusted earnings and revenue guidance for the full-year 2021 and for the first quarter. RTTNews

06:09AM EST Integra LifeSciences Sees FY21 Adj. EPS $0.54-$0.58 vs $0.64 Est., Sales $345-$355M vs $359.9M Est.; Sees FY21 Adj. EPS $2.86-$2.93 vs $2.92 Est., Sales $1.52B-$1.535B vs $1.54B Est. Benzinga

06:08AM EST Integra LifeSciences Q4 GAAP EPS $1.09 Vs $0.18 Last Year RTTNews

06:07AM EST Integra Lifesciences Q4 Adj. EPS $0.84 Beats $0.73 Estimate, Sales $388.60M Beat $388.58M Estimate Benzinga

06:00AM EST Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full-year ended December31, 2020, consistent with its preliminary revenue results announced on January 14, 2021. GlobeNewswire Inc

04:28AM EST Earnings Scheduled For February 18, 2021 Benzinga

Jan 28, 2021

08:03AM EST The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO Benzinga

Jan 27, 2021

01:14PM EST JMP Securities Maintains Market Outperform on Integra Lifesciences, Raises Price Target to $80 Benzinga

Jan 22, 2021

07:22AM EST The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa Benzinga

Jan 21, 2021

08:05AM EST The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga

Jan 20, 2021

08:40AM EST Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it completed the previously-disclosed acquisition of ACell, Inc. GlobeNewswire Inc

07:32AM EST The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study Benzinga

Jan 14, 2021

07:57AM EST The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates Benzinga

06:50AM EST Integra LifeSciences Holdings Corp. (IART), a medical technology company, on Thursday announced certain unaudited preliminary fourth quarter and full-year 2020 revenue results. RTTNews

06:33AM EST Integra LifeSciences Sees Q4 Sales $387M-$389M Vs. $389.05M Est., FY20 Sales $1.37B-$1.372B Vs. $1.37B Est. Benzinga

06:33AM EST Integra LifeSciences Expects Q4 Revenue Of $387 Mln-$389 Mln RTTNews

06:30AM EST Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today certain unaudited preliminary fourth quarter and full-year 2020 revenue results. GlobeNewswire Inc

Jan 7, 2021

09:25AM EST Credit Suisse Maintains Outperform on Integra Lifesciences, Raises Price Target to $73 Benzinga

Jan 4, 2021

12:49PM EST Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has completed its previously announced divestiture of its Extremity Orthopedics business to Smith+Nephew (LSE:SN, NYSE:SNN). GlobeNewswire Inc

Dec 29, 2020

08:09AM EST The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica Benzinga

Dec 23, 2020

08:31AM EST The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut Benzinga

Dec 21, 2020

04:01PM EST Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Peter Arduini, president and chief executive officer will present virtually at the 39th Annual J.P. Morgan Healthcare conference on January 14, 2021 at 8:20am ET. GlobeNewswire Inc

Dec 18, 2020

07:48AM EST The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data Benzinga

07:45AM EST The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data Benzinga

Dec 16, 2020

08:32AM EST Medical technology company Integra LifeSciences Holdings Corp. (IART) announced Wednesday it has entered into a definitive agreement to acquire ACell, Inc. for an upfront cash payment of $300 million at closing, subject to customary purchase price adjustments, and cash payments of up to an additional $100 million upon the achievement of certain revenue growth milestones. RTTNews

08:18AM EST Integra LifeSciences Agrees To Acquire ACell For An Upfront Cash Payment Of $300 Mln RTTNews

08:04AM EST Integra LifeSciences Announces Definitive Agreement To Acquire ACell For Upfront Cash Payment Of $300M Benzinga

08:00AM EST Integra LifeSciences Announces Definitive Agreement to Acquire GlobeNewswire Inc

Oct 29, 2020

09:46AM EDT Piper Sandler Maintains Neutral on Integra Lifesciences, Lowers Price Target to $47 Benzinga

Oct 28, 2020

07:21AM EDT Integra Lifesciences: Q3 Earnings Insights Benzinga

06:47AM EDT Integra LifeSciences Holdings Corp. (IART) reported third quarter adjusted earnings per share of $0.80, compared to $0.68, last year. On average, 13 analysts polled by Thomson Reuters expected the company to report profit per share of $0.53, for the quarter. Analysts' estimates typically exclude special items. RTTNews

06:17AM EDT Integra Lifesciences Q3 Adj. EPS $0.80 Beats $0.53 Estimate, Sales $370.23M Beat $347.98M Estimate Benzinga

06:00AM EDT Integra LifeSciences Holdings Corporation(NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September30, 2020. GlobeNewswire Inc

Oct 8, 2020

10:00AM EDT Benzinga's Top Upgrades, Downgrades For October 8, 2020 Benzinga

06:37AM EDT JP Morgan Downgrades Integra Lifesciences to Underweight, Announces $50 Price Target Benzinga

Oct 6, 2020

04:05PM EDT Integra LifeSciences Sees Prelim. Q3 Sales Of $368M-$370M Vs $340.39M Estimates Benzinga

04:01PM EDT Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today certain unaudited preliminary third quarter financial results. The company also announced that it will release full third quarter 2020 financial results on Wednesday, October 28, 2020 at 8:30 a.m. ET. GlobeNewswire Inc

Sep 29, 2020

09:29AM EDT Smith+Nephew To Acquire Extremity Orthopaedics Unit Of RTTNews

09:05AM EDT Smith+Nephew To Buy Extremity Orthopaedics Business Of Integra LifeSciences For $240 Mln RTTNews

09:04AM EDT Smith+Nephew expands in higher-growth extremities segment through planned PR Newswire

08:03AM EDT Integra LifeSciences Announces Definitive Agreement To Divest Its Extremity Orthopedics Business To Smith+Nephew For $240M Benzinga

08:00AM EDT Integra LifeSciences Announces Definitive Agreement to Divest its GlobeNewswire Inc

Sep 2, 2020

04:01PM EDT Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it will participate in two investor conferences in September. GlobeNewswire Inc

Aug 12, 2020

07:33AM EDT Truist Securities Maintains Buy on Integra Lifesciences, Raises Price Target to $60 Benzinga

Aug 11, 2020

10:44AM EDT UBS Maintains Neutral on Integra Lifesciences, Raises Price Target to $53 Benzinga

10:24AM EDT Credit Suisse Maintains Outperform on Integra Lifesciences, Raises Price Target to $60 Benzinga

Aug 10, 2020

04:13PM EDT Integra Lifesciences Q2 EPS $0.33 Beats $0.10 Estimate, Sales $258.67M Beat $242.80M Estimate Benzinga

04:01PM EDT Integra LifeSciences Holdings Corporation(NASDAQ: IART), a leading global medical technology company, today reported financial results for the second quarter ending June30, 2020. GlobeNewswire Inc

04:10AM EDT Earnings Scheduled For August 10, 2020 Benzinga

Aug 7, 2020

10:57AM EDT Integra Lifesciences Earnings Preview Benzinga

Jul 22, 2020

08:05AM EDT Integra LifeSciences Receives FDA Clearance For Specific Neurosurgery Indication For CUSA Clarity Benzinga

08:00AM EDT Integra LifeSciences Receives FDA Clearance for Specific GlobeNewswire Inc